PeptidePicker
Get Started
Home/Peptides/Cagrilintide
Weight LossClinical Trials

Cagrilintide

Also known as: AM833

An ultra-long-acting amylin analog that suppresses appetite via a pathway distinct from GLP-1, designed to shatter weight loss plateaus.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~7–8 days

Typical Dose

2.4 mg weekly

Administration

Subcutaneous injection

Mechanism of Action

Mimics amylin to activate the area postrema and central amygdala, slowing gastric emptying and reducing caloric intake through a separate neurological pathway.

Key Research Areas

weight lossamylinappetiteNovo Nordisk

Frequently Asked Questions

What is Cagrilintide?▾
An ultra-long-acting amylin analog that suppresses appetite via a pathway distinct from GLP-1, designed to shatter weight loss plateaus.
How does Cagrilintide work?▾
Mimics amylin to activate the area postrema and central amygdala, slowing gastric emptying and reducing caloric intake through a separate neurological pathway.
What is the recommended dosage for Cagrilintide?▾
The typical research dosage is 2.4 mg weekly, administered via Subcutaneous injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Cagrilintide?▾
The half-life of Cagrilintide is approximately ~7–8 days. This affects dosing frequency and timing in research protocols.
Is Cagrilintide FDA approved?▾
Cagrilintide is currently classified as "Clinical Trials" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about Cagrilintide is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Weight Loss

Semaglutide

Ozempic · Wegovy

Tirzepatide

Mounjaro · Zepbound

Retatrutide

LY3437943 · Triple G agonist

Liraglutide

Victoza · Saxenda

Back to All PeptidesFind Your Peptide — Take the Quiz